13 hours BioAge, BKV shares end their first trading day flat after earlier gains MarketWatch
Obesity-drug developer BioAge held on to a slim gain after rising more than 20%, while Texas-based Barnett Shale driller BKV traded flat.
Obesity-drug developer BioAge held on to a slim gain after rising more than 20%, while Texas-based Barnett Shale driller BKV traded flat.